Major therapeutic advances in the rehabilitation of subacute stroke are lacking. One promising approach is treatment with amphetamine in combination with physiotherapy so as to promote motor function. In a randomized, double-blind, placebo-controlled clinical trial, the effect of 10 sessions with 10 mg of amphetamine combined with physiotherapy during a 5-week period was investigated in 39 geriatric patients who had been admitted to a stroke rehabilitation unit. Motor function (Fugl-Meyer motor performance score) and activities of daily living (ADL; Barthel’s index) were assessed at baseline and at the end of treatment. All patients improved significantly over the intervention period. Amphetamine-treated patients did not show any increase in motor function or ADL as compared to the control group. Rehabilitation with amphetamine at this dosage and interval, combined with physiotherapy, did not promote motor recovery or functional capacity in patients suffering from stroke.

Keywords:
Amphetamine, Stroke, Rehabilitation
1.
Feeney DM: From laboratory to clinic: Noradrenergic enhancement of physical therapy for stroke or trauma patients. Adv Neurol 1997;73:383–394.
2.
Feeney DM, Gonzales A, Law WA: Amphetamine restores locomotor function after motor cortex injury in the rat. Proc West Pharmacol Soc 1981;24:15–17.
3.
Feeney DM, Hovda DA: Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology (Berl) 1983;79:67–71.
4.
Sutton RL, Hovda DA, Feeney DM: Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. Behav Neurosci 1989;103:837–841.
5.
Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN: Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988;23:94–97.
6.
Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R: Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995;26:2254–2259.
7.
Mazagri R, Shuaib A, McPherson M, Deighton M: Amphetamine failed to improve motor function in acute stroke. Can J Neurol Sci 1995;22:25.
8.
Reding M, Solomon B, Borucki S: Effect of dextroamphetamine on motor recovery after stroke. Neurology 1995;45:A222.
9.
Duncan PW, Propst M, Nelson SG: Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. Phys Ther 1983;63:1606–1610.
10.
Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S: The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med 1975;7:13–31.
11.
Collin C, Wade DT, Davies S, Horne V: The Barthel ADL Index: A reliability study. Int Disabil Stud 1988;10:61–63.
12.
Mahoney FI, Barthel DW: Functional evaluation: Barthel index. Md State Med J 1965;14:61–65.
13.
Buell SJ, Coleman PD: Quantitative evidence for selective dendritic growth in normal human aging but not in senile dementia. Brain Res 1981;214:23–41.
14.
Ferrucci L, Bandinelli S, Guralnik JM, Lamponi M, Bertini C, Falchini M, Baroni A: Recovery of functional status after stroke. A postrehabilitation follow-up study. Stroke 1993;24:200–205.
15.
Unwin H, Walker-Batson D: No side effects after low-dose amphetamine administration in stroke rehabilitation. Stroke 2000;31:1788–1789.
16.
Gladstone DJ, Black SA: Enhancing recovery after stroke with noradrenergic pharmacotherapy: A new frontier? Can J Neurol Sci 2000;27:97–105.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.